• Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints

Novo’s Wegovy successor disappoints in second large trial

Simon Osuji by Simon Osuji
March 10, 2025
in Technology
0
Novo shares climb on early data for dual-acting obesity drug
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly surpass Eli Lilly’s Zepbound.

Related posts

Experts ousted from CDC panel warn of damage to US vaccine policy

15 states sue HHS over changes to childhood vaccine schedule

February 25, 2026
Failure of REA boss to appear before Reps described as ‘disrespectful’ – EnviroNews

Failure of REA boss to appear before Reps described as ‘disrespectful’ – EnviroNews

February 25, 2026

Source link

Previous Post

At SXSW, Bluesky CEO Jay Graber pokes fun at Mark Zuckerberg with Latin phrase T-shirt

 Next Post

Tesla (TSLA) Stock May Get Boost From Trump Tariffs: Here’s How
Next Post
Tesla (TSLA) Stock May Get Boost From Trump Tariffs: Here’s How

Tesla (TSLA) Stock May Get Boost From Trump Tariffs: Here’s How

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Trader Turns $3.3K Into $2.5M in 3 Hours: Crypto’s Wild Ride

Trader Turns $3.3K Into $2.5M in 3 Hours: Crypto’s Wild Ride

1 year ago
What Are NFT Royalties?

What Are NFT Royalties?

3 years ago
XRP’s Record-Breaking Surge: A New Era Begins

XRP’s Record-Breaking Surge: A New Era Begins

1 year ago
Employee groups, Democrats, experts warn feds not to accept ‘deferred resignation’ offer

Employee groups, Democrats, experts warn feds not to accept ‘deferred resignation’ offer

1 year ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0

  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0

  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0

  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0

  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form

© 2026 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Fashion Intelligence

© 2023 LBNN - All rights reserved.